Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Dr. Lemlem Gebremariam Aregawi , Medicinal Chemistry , PhD Candidate at University of Debrecen, Hungary

Lemlem Gebremariam Aregawi is an Ethiopian health professional and researcher currently pursuing a Ph.D. in Nutritional Sciences at the University of Debrecen, Hungary. With over a decade of academic and clinical experience, she has made significant contributions to public health, particularly in the areas of reproductive health, clinical nutrition, and functional gastrointestinal disorders. She served in academic, research, and leadership roles at Adigrat University and Mekelle University in Ethiopia before moving to Hungary on a prestigious scholarship. Her current research explores the therapeutic potential of natural compounds like ginger, and she has presented at numerous international scientific conferences. Lemlem is a published author with more than 19 scientific papers in peer-reviewed journals, and several are currently under review. She has also served as an external examiner for multiple universities. Her multidisciplinary expertise bridges laboratory science, clinical practice, and public health interventions with a strong focus on evidence-based approaches.

Professional Profile :         

Orcid 

Summary of Suitability for Award:

Dr. Lemlem Gebremariam Aregawi is an accomplished Ethiopian researcher in Nutritional Sciences, currently pursuing her Ph.D. at the University of Debrecen, Hungary. Her dedication to advancing clinical nutritional research, particularly involving ginger supplementation and gastrointestinal health, has resulted in over 19 peer-reviewed publications, with multiple clinical trials and systematic reviews in high-impact journals such as Current Therapeutic Research, Advances in Integrative Medicine, and Clinical Nutrition Open Science. Her work is pioneering in its translational focus on using natural compounds to improve public health outcomes. Given her extensive research output, commitment to evidence-based public health interventions, and international academic footprint, Dr. Lemlem Gebremariam Aregawi is a highly suitable candidate for the “Best Researcher Award”. Her work exemplifies the integration of scientific rigor, clinical relevance, and community health impact—making her an outstanding researcher deserving of global recognition.

🎓Education:

Lemlem Gebremariam Aregawi is a Ph.D. candidate in Nutritional Sciences at the University of Debrecen, Hungary (2019–present), where she is conducting clinical trial-based research focusing on dietary interventions and gastrointestinal health. She earned her Master of Public Health in Reproductive Health from Mekelle University, Ethiopia (2011–2013), gaining deep insights into maternal and child health and community-based healthcare strategies. Prior to that, she completed her Bachelor of Science in Medical Laboratory Technology at Jimma University, Ethiopia (2004–2006), where she developed solid clinical and laboratory diagnostic skills. Her academic journey is enriched with various specialized trainings from institutions such as Virge University in the Netherlands, and multiple pedagogical certifications from programs sponsored by USAID and the Ethiopian Ministry of Education. Her education reflects a rich integration of scientific research, health promotion, laboratory diagnostics, and public health practice—laying a strong foundation for her ongoing research and academic pursuits in nutritional science.

🏢Work Experience:

Lemlem Gebremariam Aregawi has accumulated diverse experience in academia, healthcare, and research over nearly two decades. Since 2019, she has been a Ph.D. researcher at the University of Debrecen, Hungary, working on clinical trials evaluating the nutritional effects of ginger. Prior to this, she served as Assistant Professor and Head of Research and Community Services at Adigrat University, Ethiopia (2014–2019), where she also taught public health and coordinated community programs. She worked briefly as a Clinical Laboratory Expert at Ayder Comprehensive Specialized Hospital, Mekelle University (2013–2014), and previously as Assistant Lecturer and Department Head at Mekelle Health Sciences College (2007–2011). Her early career began as a Medical Laboratory Technologist at Axum St. Merry Hospital (2006–2007). She has also served as an external examiner at Mekelle and Axum Universities. Lemlem’s roles span education, laboratory diagnostics, health systems strengthening, and nutritional research, reflecting her multidisciplinary expertise and leadership.

🏅Awards: 

Lemlem Gebremariam Aregawi has been recognized for her academic excellence, leadership, and commitment to public health. She is a recipient of a competitive international scholarship to pursue her Ph.D. studies in Hungary, highlighting her research potential and academic distinction. Throughout her career in Ethiopia, she earned accolades for her outstanding contributions as Head of Research and Community Services at Adigrat University. Lemlem has also been selected as an external examiner for both undergraduate and postgraduate students, reflecting her academic credibility and peer recognition. She has completed prestigious international training, including a pre-doctoral program at Virge University, Amsterdam. Additionally, she received multiple certifications from USAID-sponsored initiatives and Ethiopia’s Ministry of Education, including Training of Trainers (ToT) certifications on sexual and reproductive health, curriculum development, and biosafety. These honors and professional development achievements underscore her commitment to quality education, public health, and global scientific collaboration.

🔬Research Focus:

Lemlem Gebremariam Aregawi’s research centers on the role of nutritional interventions—particularly ginger—in preventing and managing chronic gastrointestinal conditions and metabolic disorders. As a Ph.D. candidate, she is currently engaged in clinical trials investigating the efficacy, safety, and quality-of-life impacts of ginger supplementation in patients with functional dyspepsia. Her broader interests include the therapeutic role of bioactive compounds in disease prevention, integrative medicine, reproductive health, and public health nutrition. She has authored several systematic reviews on ginger’s pharmacological effects, including its impact on body weight, gastrointestinal malignancies, diabetes mellitus, and inflammatory bowel disease. Lemlem’s work bridges clinical nutrition, public health, and biomedical sciences, offering evidence-based insights into the dietary management of chronic diseases. Her multidisciplinary approach enables her to evaluate both biological mechanisms and public health implications of nutritional therapies, with the ultimate goal of translating scientific findings into practical dietary recommendations and health policies.

Publication Top Notes:

“Ginger’s Nutritional Implication on Gastrointestinal Health”

“Evaluation of Adverse Effects and Tolerability of Dietary Ginger Supplementation in Patients with Functional Dyspepsia”

“Effects of Ginger Supplementation on Quality of Life in Patients with Functional Dyspepsia: An Open-Label, Clinical Trial”

“Preventive and Therapeutic Effects of Ginger on Bowel Disease: A Review of Clinical Trials”

“The Effect of Ginger Supplementation on the Improvement of Dyspeptic Symptoms in Patients With Functional Dyspepsia”

“Ginger Constituents and Its Effects on Gastrointestinal Malignancies: A Review of Clinical Trials”

“Assessment of Service Satisfaction and Associated Status Among Women Who Have Given Birth in Adigrat General Hospital, Ethiopia”

“Prevalence and Determinants of Modern Contraceptive Utilization Among Women in the Reproductive Age Group in Edaga-Hamus Town, Eastern Zone, Tigray Region, Ethiopia”

 

 

Dr. Xufen Yu | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Xufen Yu | Medicinal Chemistry | Best Researcher Award

Dr. Xufen Yu | Medicinal Chemistry | Associate Professor at Fudan University, China

Dr. Xufen Yu is an Associate Professor in the Department of Medicinal Chemistry at Fudan University’s School of Pharmacy. She specializes in drug discovery, chemical biology, and targeted protein degradation, particularly in cancer therapeutics. Before joining Fudan University, she was an Instructor and Postdoctoral Fellow at the Icahn School of Medicine at Mount Sinai, where she contributed significantly to pharmacological sciences. Dr. Yu has also held postdoctoral positions at Purdue University and the University of Hawaii at Hilo. She holds a Ph.D. from the Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry. Her research has led to numerous high-impact publications in journals such as Journal of Medicinal Chemistry, Oncogene, and Nature Cancer. With extensive expertise in PROTAC-based therapeutics and epigenetic regulation, Dr. Yu continues to make significant contributions to the field of medicinal chemistry and targeted cancer therapy.

Professional Profile : 

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Dr. Xufen Yu is an exceptionally accomplished researcher in medicinal chemistry, with significant contributions to drug discovery, targeted protein degradation, and epigenetics. Her extensive academic background, including a Ph.D. from the Chinese Academy of Sciences and postdoctoral research at prestigious institutions such as Purdue University and the Icahn School of Medicine at Mount Sinai, demonstrates her expertise in chemical biology and small-molecule therapeutics. She has consistently advanced the field through high-impact publications, innovative research, and groundbreaking discoveries in PROTACs and DUBTACs, which have transformed targeted cancer therapy.  Given her outstanding achievements, innovative research, and contributions to medicinal chemistry, Dr. Xufen Yu is highly suitable for the “Best Researcher Award”. Her pioneering work in targeted protein degradation, combined with her international recognition and research excellence, makes her a strong candidate. Her research has not only advanced scientific knowledge but also holds significant promise for therapeutic applications, reinforcing her eligibility for this distinguished honor.

🎓Education:

Dr. Xufen Yu earned her Ph.D. in Organic Chemistry from the Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry, in 2011. Her doctoral research focused on synthetic organic chemistry and drug discovery. Prior to that, she completed her undergraduate studies at Anhui University, Hefei, China, earning a Bachelor’s degree in Chemistry in 2006. With a strong academic foundation, Dr. Yu developed expertise in medicinal chemistry, chemical biology, and targeted protein degradation. Her educational journey equipped her with extensive knowledge of molecular design, synthetic methodologies, and structure-activity relationship studies, laying the groundwork for her future contributions to pharmacological sciences. Her rigorous training in organic synthesis and chemical biology has driven her impactful research in developing novel therapeutics, particularly in targeted protein degradation and epigenetic regulation.

🏢Work Experience:

Dr. Xufen Yu has had a distinguished career in academia and research, with extensive postdoctoral and faculty experience. She is currently an Associate Professor in the Department of Medicinal Chemistry at Fudan University, Shanghai, China. Before joining Fudan, she was an Instructor in the Department of Pharmacological Science at the Icahn School of Medicine at Mount Sinai, New York (2021–2022), following a postdoctoral fellowship at the same institution from 2017 to 2020. She also worked as a postdoctoral fellow in Chemistry at Purdue University (2013–2014) and in Pharmaceutical Science at the University of Hawaii at Hilo (2011–2013). Through these roles, she has contributed significantly to medicinal chemistry, focusing on drug discovery, targeted protein degradation, and cancer therapeutics. Her work across multiple prestigious institutions reflects her expertise in interdisciplinary research, integrating chemistry and pharmacology to develop novel small-molecule therapeutics.

🏅Awards: 

Dr. Xufen Yu has been recognized for her outstanding contributions to medicinal chemistry and drug discovery. She has received multiple awards and research grants for her pioneering work in targeted protein degradation and epigenetics. Her innovative research has been acknowledged with prestigious fellowships and funding from institutions such as the National Institutes of Health (NIH) and the Chinese Academy of Sciences. Additionally, she has been honored for her significant publications in high-impact journals, receiving accolades for breakthrough studies on PROTACs and epigenetic regulators in cancer therapy. Her commitment to scientific excellence has led to invitations as a speaker at international conferences, where she has shared her expertise in medicinal chemistry. Dr. Yu’s contributions have been instrumental in advancing chemical biology and therapeutic discovery, making her a well-respected figure in her field.

🔬Research Focus:

Dr. Xufen Yu’s research focuses on the development of novel therapeutic strategies targeting disease-related proteins, particularly in cancer and metabolic disorders. Her expertise lies in targeted protein degradation, including the design and synthesis of PROTACs (Proteolysis Targeting Chimeras) and DUBTACs (Deubiquitinase Targeting Chimeras). She has explored epigenetic regulation in cancer therapy, investigating how small molecules can modulate oncogenic transcription factors and chromatin regulators. Her work also includes studying the role of ubiquitin-proteasome and autophagy systems in disease mechanisms, aiming to develop highly selective small-molecule therapeutics. Through interdisciplinary approaches combining medicinal chemistry, chemical biology, and pharmacology, she has contributed to advancing targeted cancer treatments. Dr. Yu’s research has led to the discovery of several potent and selective degraders for oncogenic proteins such as EZH2, WDR5, and USP7, paving the way for new treatment modalities in oncology.

Publication Top Notes:

Macrocyclic drugs and synthetic methodologies toward macrocycles
Authors: X Yu, D Sun
Citations: 276
Year: 2013

Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism
Authors: AJ Bott, J Shen, C Tonelli, L Zhan, N Sivaram, YP Jiang, X Yu, V Bhatt, …
Citations: 155
Year: 2019

Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders
Authors: M Cheng, X Yu, K Lu, L Xie, L Wang, F Meng, X Han, X Chen, J Liu, …
Citations: 151
Year: 2020

EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
Authors: J Wang, X Yu, W Gong, X Liu, KS Park, A Ma, YH Tsai, Y Shen, T Onikubo, …
Citations: 134
Year: 2022

A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
Authors: X Yu, D Li, J Kottur, Y Shen, HS Kim, KS Park, YH Tsai, W Gong, J Wang, …
Citations: 103
Year: 2021

Discovery of first-in-class protein arginine methyltransferase 5 (PRMT5) degraders
Authors: Y Shen, G Gao, X Yu, H Kim, L Wang, L Xie, M Schwarz, X Chen, …
Citations: 84
Year: 2020

Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery
Authors: AM Chiarella, KV Butler, BE Gryder, D Lu, TA Wang, X Yu, S Pomella, …
Citations: 77
Year: 2020

Cationic Palladium Complex Catalyzed Diastereo-and Enantioselective Tandem Annulation of 2-Formylarylboronic Acids with Allenoates
Authors: X Yu, X Lu
Citations: 57
Year: 2009

AKT degradation selectively inhibits the growth of PI3K/PTEN pathway–mutant cancers with wild-type KRAS and BRAF by destabilizing aurora kinase B
Authors: J Xu, X Yu, TC Martin, A Bansal, K Cheung, A Lubin, E Stratikopoulos, …
Citations: 51
Year: 2021

Design, synthesis, and evaluation of potent, selective, and bioavailable AKT kinase degraders
Authors: X Yu, J Xu, L Xie, L Wang, Y Shen, KM Cahuzac, X Chen, J Liu …
Citations: 42
Year: 2021

Assoc. Prof. Dr. Ranjan Khunt | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ranjan Khunt | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Ranjan Khunt , Saurashtra University , India

Dr. Ranjan C. Khunt is an accomplished Associate Professor in the Department of Chemistry at Saurashtra University, Rajkot, with over 25 years of teaching and 20 years of research experience. He holds an M.Sc. and Ph.D. from Saurashtra University, specializing in Heterocyclic Medicinal Chemistry, Nano-Science, and Spectroscopy. Dr. Khunt has significantly contributed to nano-science and method development, focusing on advancing spectroscopy and medicinal chemistry. He has published 105 research papers and holds 7 patents. With a track record of guiding 14 research students and mentoring 3 current students, Dr. Khunt is committed to fostering the next generation of chemists. His leadership is further demonstrated by his academic service, including serving as a member of the National Magnetic Resonance Society and receiving recognition for his teaching excellence and research achievements.

Professional Profile

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Ranjan C. Khunt is highly suitable for the Best Researcher Award due to his remarkable contributions in Medicinal Chemistry, Nano-Science, and Spectroscopy. With over 20 years of research experience, Dr. Khunt has authored 105 research papers and holds 7 patents, underscoring his prolific output and innovation in the field. His focus on developing novel heterocyclic compounds with potential medicinal applications, as well as his expertise in nano-materials for environmental and medical purposes, has had a significant impact on both theoretical and applied chemistry. Moreover, his contributions to spectroscopic methods have advanced chemical analysis techniques. Dr. Khunt’s leadership in guiding 14 research students and his mentorship in a wide array of interdisciplinary projects demonstrate his commitment to fostering future researchers. His numerous awards, including the Best Teacher Award and recognition by institutions like the National Magnetic Resonance Society, further solidify his candidacy for this prestigious honor.

🎓Education:

Dr. Ranjan C. Khunt’s educational journey began at Saurashtra University, where he completed both his M.Sc. and Ph.D. in Chemistry. His doctoral research focused on Heterocyclic Medicinal Chemistry, a field that would shape his subsequent career. Throughout his academic journey, he gained extensive knowledge in Nano-Science and Spectroscopy, which became key areas of his research expertise. Dr. Khunt’s research interests in these fields reflect a strong foundation in both theoretical and practical aspects of chemistry. His academic qualifications provided him with a robust understanding of the intersection between chemistry, medicinal applications, and cutting-edge technological developments. Dr. Khunt’s commitment to his education extended beyond the classroom as he engaged in continuous learning and contributed to the field’s advancement through teaching and research at Saurashtra University, where he remains an influential figure in the academic community.

🏢Work Experience:

Dr. Ranjan C. Khunt has a distinguished teaching and research career spanning over 25 years. He has been an Associate Professor at the Department of Chemistry, Saurashtra University, Rajkot, for more than two decades, where he has mentored numerous students and played a pivotal role in the university’s academic development. His expertise spans Heterocyclic Medicinal Chemistry, Nano-Science, Spectroscopy, and Method Development and Validation. With 20 years of research experience, Dr. Khunt has led groundbreaking work in these fields, contributing to the development of new methods and technologies. In addition to his teaching responsibilities, he has guided 14 research students, fostering a research-driven environment at the university. Dr. Khunt’s academic career is also marked by 17 invitations from other institutions, reflecting his reputation as a leader in his field. His research projects have resulted in valuable advancements, and his work continues to influence the future of chemistry education and research.

🏅Awards: 

Dr. Ranjan C. Khunt’s academic and professional excellence has been recognized through various prestigious awards and honors. He was awarded the Best Teacher Award by the Institute of Scholars, which acknowledged his exceptional teaching abilities and commitment to student development. In addition, he received the Nation Builder’s Award from the Rotary Club of Rajkot Prime, a testament to his contributions to education and society. Dr. Khunt was honored with the Fast Track Young Scientist Fellowship, which highlighted his emerging role in advancing scientific research. He also serves as an Executive Committee Member of the National Magnetic Resonance Society, Bangalore, an esteemed position that reflects his influence in the field of spectroscopy. These recognitions, along with 6 research projects and his impressive publication record, underscore Dr. Khunt’s dedication to the scientific community, educational excellence, and innovation.

🔬Research Focus:

Dr. Ranjan C. Khunt’s research focuses on the intersection of Medicinal Chemistry, Nano-Science, and Spectroscopy, areas in which he has made significant advancements. His expertise in Heterocyclic Chemistry has led to the development of novel compounds with medicinal applications, especially those aimed at improving health outcomes. Dr. Khunt’s work in Nano-Science is driven by the exploration of nanomaterials for use in various chemical processes and their applications in drug delivery systems, diagnostics, and therapeutic interventions. Additionally, his contributions to Spectroscopy and Method Development have been fundamental in advancing analytical techniques, aiding in precise measurement and characterization of chemical compounds. His research aims to bridge the gap between fundamental chemical knowledge and practical applications in medicine, pharmaceuticals, and environmental chemistry. Dr. Khunt’s work is critical for advancing both the theoretical and practical aspects of modern chemistry, especially in sustainable and health-related areas.

Publication Top Notes:

Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives
Authors: RC Khunt, VM Khedkar, RS Chawda, NA Chauhan, AR Parikh, …
Journal: Bioorganic & Medicinal Chemistry Letters
Citations: 109
Year: 2012

Synthesis of some new heterocyclic compounds with potential biological activity
Authors: DP Bhoot, RC Khunt, VK Shankhavara, HH Parekh
Journal: Journal of Sciences, Islamic Republic of Iran
Citations: 36
Year: 2006

Plant pigments as dietary anticancer agents
Author: RK Upadhyay
Journal: International Journal of Green Pharmacy (IJGP)
Citations: 33
Year: 2018

Synthesis of certain 1, 3, 4-oxadiazoles as potential antitubercular and antimicrobial agents
Authors: SR Dhol, AS Bhimani, RC Khunt, AR Parikh
Journal: Indian Journal of Heterocyclic Chemistry
Citations: 25
Year: 2005

Synthesis and biological evaluation of cyanopyridine and isozazole derivatives
Authors: RC Khunt, NJ Datta, FM Bharmal, GP Mankad, AR Parikh
Journal: Indian Journal of Heterocyclic Chemistry
Citations: 24
Year: 2000

Discovery of hybrid purine-quinoline molecules and their cytotoxic evaluation
Authors: KM Kapadiya, RC Khunt
Journal: Letters in Drug Design & Discovery
Citations: 23
Year: 2019

Synthesis of Purine‐based Triazoles by Copper (I)‐catalyzed Huisgen Azide–Alkyne Cycloaddition Reaction
Authors: K Kapadiya, Y Jadeja, R Khunt
Journal: Journal of Heterocyclic Chemistry
Citations: 23
Year: 2018

Synthesis of some new 4-thiazolidinones as biologically potent agents
Authors: NJ Datta, RC Khunt, AR Parikh
Journal: NISCAIR-CSIR, India
Citations: 23
Year: 2002

Dihedral angle study in Hesperidin using NMR Spectroscopy
Authors: YS Jadeja, KM Kapadiya, HJ Jebaliya, AK Shah, RC Khunt
Journal: Magnetic Resonance in Chemistry
Citations: 21
Year: 2017

UV-Vis spectrophotometric assay determination of oral antiplatelet ticagrelor drug in pharmaceutical formulation: Application to content uniformity
Authors: D Pandya, M Patel, R Ghediya, A Shah, R Khunt
Journal: Journal of Chemical and Pharmaceutical Research
Citations: 20
Year: 2016

 

 

 

 

 

Dr. Batoul Rostom | Medicinal Chemistry Award | Best Researcher Award

Posted on by sciencefather

Dr. Batoul Rostom | Medicinal Chemistry Award | Best Researcher Award

Dr. Batoul Rostom , INSERM-CRM , France

🎓 Dr. Batoul Rostom is a dedicated researcher in medicinal chemistry, currently a postdoctoral fellow at INSERM-Centre de Recherche en Myologie, Sorbonne University. She earned her Ph.D. in Medicinal Chemistry and Cancer Biology, where she focused on synthesizing novel cyclocoumarol derivatives with dual COX-2 inhibitory and anticancer properties. Dr. Rostom has a solid academic foundation in biochemistry and reproductive biology, with experience spanning bioinformatics, synthetic chemistry, and immunology. Her research addresses pressing issues in cancer therapeutics and autoimmune diseases. She has authored impactful publications, contributed to scientific conferences, and mentored students. Dr. Rostom’s work combines innovation with clinical relevance, aiming to bridge the gap between bench research and therapeutic applications.

Professional Profile:

Google Scholar 

Orcid 

Scopus 

Summary of Suitability for Award:

Dr. Batoul Rostom’s remarkable achievements, interdisciplinary expertise, and impactful research make her a deserving candidate for the “Best Researcher Award.” Her ability to translate complex scientific concepts into therapeutic applications reflects her commitment to advancing both knowledge and societal well-being. Dr. Batoul Rostom exemplifies the qualities of an outstanding researcher, with her innovative contributions to medicinal chemistry and cancer biology. Her groundbreaking work in synthesizing cyclocoumarol derivatives as dual COX-2 inhibitors with anticancer properties showcases her ability to address pressing global health challenges.  Dr. Rostom’s impressive academic journey, from her Ph.D. at HESAM University to her postdoctoral role at Sorbonne University, highlights her dedication to advancing science.

🎓Education:

Dr. Batoul Rostom has a strong academic foundation in medicinal chemistry, biochemistry, and reproductive biology. She earned her Ph.D. in Medicinal Chemistry and Cancer Biology from HESAM University in France, where she focused on synthesizing novel cyclocoumarol derivatives with dual COX-2 inhibitory and anticancer properties. Her master’s degree in Reproductive Biology and Medical Aids from Lebanese University  centered on the impact of smoking on TET gene expression in sperm cells, optimizing RNA extraction techniques. She holds a bachelor’s degree in General Biochemistry from Lebanese University, with comprehensive training in molecular biology and biochemistry. Her education integrates interdisciplinary skills, blending synthetic chemistry, molecular biology, and bioinformatics.

🏢Work Experience:

Dr. Batoul Rostom’s career spans diverse research roles. As a postdoctoral researcher at INSERM-Centre de Recherche en Myologie, Sorbonne University , she develops therapeutic strategies for autoimmune myositis and cancer. During her Ph.D. research at CNAM in France, she synthesized and tested innovative cyclocoumarol derivatives targeting COX-2 and cancer pathways.  She led a COVID-19 PCR diagnostic team at Al Hadi Clinic, Lebanon, managing high-pressure operations during the pandemic. She has served as a private tutor , mentoring students in molecular biology and biochemistry. Her master’s internship explored smoking’s effects on male fertility, showcasing her diverse expertise.

🏅Awards:

Dr. Rostom’s remarkable achievements have earned her significant recognition in the field of medicinal chemistry. She was nominated for the prestigious International Chemistry Scientist Award for her groundbreaking contributions. As an active member of the Société de Chimie Thérapeutique (SCT), her work in therapeutic compound design has been highly acknowledged. Her Ph.D. journey was supported by a competitive Scholarship Award, highlighting her academic excellence. Dr. Rostom also received the Top Oral Communication Award for her impactful presentations and the Young Research Fellow Distinction for her exceptional poster contributions at SCT’s events. These accolades underscore her innovation, dedication, and influence in advancing scientific research.

🔬Research Focus:

Dr. Rostom’s research spans medicinal chemistry, synthetic biology, and molecular biology. She specializes in designing novel cyclocoumarol derivatives, focusing on dual COX-2 inhibitors with anticancer properties. Her expertise extends to synthetic chemistry, developing compounds with pharmacological relevance. Molecular biology techniques, including RT-qPCR, ELISA, confocal microscopy, and cell culture, are central to her work. Her master’s research delved into reproductive biology, investigating smoking’s effects on male fertility. Presently, she focuses on autoimmune diseases, designing therapies for myositis while leveraging bioinformatics for in silico compound development. Her interdisciplinary approach aims to bridge laboratory research with clinical applications.

Publication Top Notes:

    • “Fishing antioxidant 4-hydroxycoumarin derivatives: synthesis, characterization, and in vitro assessments”
    • “Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways”
      • Citations: 34 citations